Search results :

Tenofovir disoproxil fumarate

More information: STITCH, PubChem (stereo-specific compound: 1) and possibly Wikipedia

ATC Code: J05AF07

Side effects

Options: Hide MedDRA Preferred Terms

MedDRA Preferred Term Side effect Data for drug Placebo Labels
1 2 3 4 5 6 7 8 9 10 11 12 13
Pruritus Pruritus 16% x x x x x x x x x x
Nasopharyngitis Nasopharyngitis 9.86% - 11.2% x x x x x x
Nausea Nausea postmarketing — 2.79% - 20% 5% - 10% x x x x x x x x x x x x x
Fasting Fasting 2% - 24% x x x x x
Pain Pain 7% - 12% 7% x x x x x x x x x x
Diarrhoea Diarrhoea postmarketing — 5.12% - 16% 8% - 10% x x x x x x x x x x x x x
Asthenia Fatigue 7.44% - 8.45% x x x x x x
Asthenia postmarketing — 7% - 11% 6% - 8% x x x x x x x x x x x x x
Fatigue Fatigue 7.44% - 8.45% x x x x x x
Headache Headache 5% - 14% 5% - 7% x x x x x x x x x x x x
Abdominal pain upper Abdominal pain upper 5.12% - 7.04% x x
Depression Depression 4% - 8% 3% x x x x x x x x x x
Vomiting Vomiting postmarketing — 4% - 13% 1% - 2% x x x x x x x x x x x x x
Procedural pain Procedural pain 3.76% - 5.58% x
Back pain Back pain 3% - 7.04% 3% x x x x x x x x x x
Laryngeal pain Pharyngolaryngeal pain 3.52% - 5.12% x
Upper respiratory tract infection Upper respiratory tract infection 3.05% - 5.12% x x x x x x
Body temperature increased Body temperature increased 2% - 11% 2% x x x x x x x x x x
Flatulence Flatulence postmarketing — 3% - 4% 0% - 1% x x x x x x x x x x x x x
Neuropathy peripheral Neuropathy peripheral 3% - 5% 3% x x x x x x x x x x
Neuritis x x x x x x x x x x
Neuropathy x x x x x x x x x x
Insomnia Insomnia 3% - 18% 2% x x x x x x x x x x
Dyspepsia Dyspepsia 3% - 4% 2% x x x x x x x x x x
Myalgia Myalgia 3% - 4% 3% x x x x x x x x x x
Musculoskeletal discomfort Myalgia 3% - 4% 3% x x x x x x x x x x
Arthralgia x x x x x x x x x x
Dizziness Dizziness postmarketing — 1% - 13% 3% x x x x x x x x x x x x
Decreased appetite Anorexia 3% - 4% 1% - 2% x x x x x x x x x x x x
Chest pain Chest pain 3% 1% x x x x x x x x x x
Hyperhidrosis Sweating 3% 2% x x x x x x x x x x
Weight decreased Weight decreased 2% - 4% 1% x x x x x x x x x x
Transaminases increased Transaminases increased postmarketing, common x
Pneumonia Pneumonia 2% - 3% 0% x x x x x x x x x x
Haematuria Haematuria 2% - 3% x x x x x x x x x x
Glycosuria Glycosuria 1% - 3% x x
Hyperglycaemia Hyperglycaemia postmarketing, 1% - 2% x x x x x x x
Abdominal pain Abdominal pain postmarketing, 3% - 22% 3% x x x x x x x x x x x x
Gastrointestinal pain Abdominal pain postmarketing, 3% - 22% 3% x x x x x x x x x x x x
Lactic acidosis Lactic acidosis postmarketing, rare x x x x x x x x x x x x
Angioedema Angioedema postmarketing, rare x x
Autoimmune disorder Autoimmune disorder postmarketing x
Connective tissue disorder Connective tissue disorder postmarketing x x x x x x
Dyspnoea Dyspnoea postmarketing x x x x x x x x x x x
Dermatitis Rash postmarketing — 5% - 7% 4% x x x x x x x x x x x x
Rash Rash postmarketing — 5% - 7% 4% x x x x x x x x x x x x
Fanconi syndrome Fanconi syndrome postmarketing, rare x x x x x x x x x x x x
Renal tubular disorder Fanconi syndrome postmarketing, rare x x x x x x x x x x x x
Multiple fractures Fracture postmarketing, rare x x x
Fracture Fracture postmarketing, rare x x x
Gastrointestinal disorder Gastrointestinal disorder postmarketing x x x x x x x x x x x
Basedow's disease Basedow's disease postmarketing x
Hepatitis Hepatitis postmarketing, rare x x x x x x x x x
Hepatomegaly Hepatomegaly postmarketing x x
Hypercholesterolaemia Hypercholesterolaemia postmarketing x
Hypersensitivity Hypersensitivity postmarketing x x x x x x x x x x
Hypertriglyceridaemia Hypertriglyceridaemia postmarketing x
Blood triglycerides increased Hypertriglyceridaemia postmarketing x
Breast enlargement Hypertrophy of breast postmarketing x
Hypokalaemia Hypokalaemia postmarketing, uncommon x x x
Immune system disorder Immune system disorder postmarketing x x x x x x x x x x
Inflammation Inflammation postmarketing x x x
Insulin resistance Insulin resistance postmarketing x
Renal failure acute Renal failure acute postmarketing, rare x x x x x x x x x x x
Renal tubular necrosis Nephrosis lower nephron postmarketing, rare x x x x x x x x x x x
Lipodystrophy acquired Lipodystrophy postmarketing x x x x x x x x x
Mediastinal disorder Mediastinal disorder postmarketing x x x x x x x x x x
Myopathy Myopathy postmarketing, rare x x x x x x
Nephritis Nephritis postmarketing, rare x x
Tubulointerstitial nephritis Nephritis interstitial postmarketing x x x x x
Acute interstitial nephritis postmarketing, rare x
Nervous system disorder Nervous system disorder postmarketing x x x x x x x
Opportunistic infection Opportunistic infection postmarketing x
Osteomalacia Osteomalacia postmarketing, rare x x x x x x
Osteonecrosis Osteonecrosis postmarketing x
Pancreatitis Pancreatitis postmarketing, uncommon x x x x x x x x x x x x
Polyuria Polyuria postmarketing x x x x x x
Urine output increased Polyuria postmarketing x x x x x x
Proteinuria Proteinuria postmarketing x x x x x x x x x x
Protein urine present Proteinuria postmarketing x x x x x x x x x x
Renal failure Renal failure postmarketing, rare x x x x x x x x x x x x
Renal impairment postmarketing x x x x x x x
Rhabdomyolysis Rhabdomyolysis postmarketing, uncommon x x x
Thrombocytopenia Thrombocytopenia postmarketing x
Urethral disorder Urinary tract disorder postmarketing x x x x x x x x x x x
Urinary tract disorder Urinary tract disorder postmarketing x x x x x x x x x x x
Hypophosphataemia Hypophosphataemia postmarketing, very common x x x x x x x x x x x x
Amylase increased Amylase increased postmarketing x x x x x x x x
Blood creatinine increased Creatinine increased postmarketing, uncommon x x x x x x x x x x x x
Serum creatinine increased x
Muscular weakness Muscular weakness postmarketing, uncommon x x x
Bone pain Bone pain postmarketing, rare x x x
Nephrogenic diabetes insipidus Nephrogenic diabetes insipidus postmarketing, rare x x x x x x x x x
Malnutrition Malnutrition postmarketing x x x x x x x x x x x
Skin disorder Unspecified disorder of skin and subcutaneous tissue postmarketing, 5% x x x x x x x
Hepatobiliary disease Hepatobiliary disease postmarketing x x x x x x x x x
Lipohypertrophy Buffalo hump postmarketing x
Hyperlactacidaemia Hyperlactacidaemia postmarketing x
Symptomatic hyperlactatemia postmarketing x
Renal impairment Renal impairment postmarketing x x x x x x x
Hepatic steatosis Hepatic steatosis postmarketing, rare x x x
Anaemia Anaemia x x
Anxiety Anxiety x x x x x x x x
Arthralgia Arthralgia x x x x x x x x x x
Mental disorder Mental disorder x x x x x x
Hepatitis B Hepatitis B x x
Metabolic disorder Metabolic disorder x x x x x x x x
Neuritis Neuritis x x x x x x x x x x
Paraesthesia Paraesthesia x x
Prurigo Prurigo x
Sinusitis Sinusitis x x x x x
Urticaria Urticaria x x x x x x x x x x
Rash pustular Rash pustular x x x x x x x x x x
Vesiculobullous rash x x x x x x x x x x
Dermatitis bullous Vesiculobullous rash x x x x x x x x x x
Alanine aminotransferase increased Alanine aminotransferase increased x
Haemoglobin decreased Haemoglobin decreased x
Rash macular Rash macular x
Rash vesicular Rash vesicular x
Abnormal dreams Abnormal dreams x x x x x x x
Rash maculo-papular Rash maculo-papular x x x x x x x x x x
Rash generalised Rash generalised x
Infestation Infestation NOS x x x x x
Exfoliative rash Exfoliative rash x
Somnolence Somnolence x x x x

Indications

Information about indications was extracted from the indications and usage sections of the labels.

tenofovir disoproxil fumarate / VIREAD

Side effects:8
Source:FDA

tenofovir disoproxil fumarate / VIREAD

Side effects:17
Source:FDA

TENOFOVIR DISOPROXIL FUMARATE / VIREAD

Side effects:49
Source:FDA

tenofovir disoproxil fumarate / VIREAD

Side effects:49
Source:FDA

tenofovir disoproxil fumarate / Viread

Side effects:55
Source:FDA

TENOFOVIR DISOPROXIL FUMARATE / VIREAD

Side effects:55
Source:FDA

VIREAD tablets / Viread, Film coated tablet

Side effects:83
Source:Medsafe

TENOFOVIR DISOPROXIL FUMARATE / VIREAD

Side effects:69
Source:FDA

TENOFOVIR DISOPROXIL FUMARATE / VIREAD

Side effects:71
Source:FDA

tenofovir disoproxil fumarate / Viread

Side effects:72
Source:FDA

tenofovir disoproxil fumarate / Viread

Side effects:78
Source:FDA

Color scheme:

standard – alternative

    100%
    75%
    50%
    10%
    frequent (1% to 100%)
    infrequent (0.1% to 1%)
    rare (<0.1%)
    postmarketing
    0%
    no frequency information
    not found on label